Teleflex shares slump as hurricane impact weighs on annual revenue forecast
Rewrites paragraph 1 to reflect revenue forecast cut, adds comments from conference call in paragraphs 2,3,7,9
By Mariam Sunny
Oct 31 (Reuters) -Teleflex TFX.N shares dropped more than 16% on Thursday, after the surgical instrument maker cut its annual revenue forecast to reflect canceled surgeries in the current quarter and an ongoing shortage of intravenous saline fluids in the United States.
The company said it saw cancellations of some procedures early in the fourth quarter due to disruptions from recent hurricanes in the U.S.
CEO Liam Kelly said on the earnings conference call that the company expects this to be a "short term, temporary" impact to its operations.
Teleflex now expects its annual revenue to grow between 2.9% and 3.4%, down from a 3.4% to 4.4% increase expected earlier.
Production at Baxter International's BAX.N North Carolina plant, which makes 60% of the United States' supply of IV fluids, was temporarily closed late last month due to flooding caused by the Hurricane Helene.
The shortage of IV products is forcing hospitals to defer elective procedures and could hurt companies that make related medical devices, according to analysts.
Besides, Kelly said Teleflex's OEM segment, which makes instruments for other device manufacturers, saw an "unanticipated softness" in the third quarter.
The unit reported quarterly sales of $82.6 million, below estimates of $88.95 million, a consensus of four analysts compiled by LSEG showed.
Teleflex said its quarterly results were also impacted by an ongoing doctors' strike in South Korea, which it expects to linger through the remainder of the year.
Revenue for the third quarter rose 2.4% to $764.4 million, but missed estimates of $769.6 million.
Adjusted profit per share of $3.49 for the three months ended Sept. 29 topped estimates of $3.39.
The Wayne, Pennsylvania-based company also raised the lower end of its 2024 adjusted per-share profit forecast to $13.90 from $13.80 previously, while keeping the upper end at $14.20.
Reporting by Puyaan Singh and Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
